Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)

• Status: Completed
• Trial end date: 2009-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to evaluate and compare the comfort of bromfenac or nepafenac following SLT.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bp Consulting, Inc
• Treatments: Anti-Inflammatory Agents, Non-Steroidal; Bromfenac; Nepafenac; Ophthalmic Solutions

Criteria

Inclusion Criteria:

• > 18 years old, either gender or any race.

• Diagnosis of open-angle glaucoma or ocular hypertension requiring laser trabeculoplasty.

• Completion of written and informed consent/authorization prior to any study related procedures.

• Able to follow study protocol and likely to complete study schedule.

Exclusion Criteria:

• Known sensitivity to NSAIDs.

• History of neovascular or ocular inflammatory disease.

• Current use of topical or systemic anti-inflammatory medications.

• Females of childbearing potential.